CSII Fundamental Analysis - CARDIOVASCULAR SYSTEMS INC

Name: CARDIOVASCULAR SYSTEMS INC (CSII) Stock
Brand: CARDIOVASCULAR SYSTEMS INC
Rating: 5.5 (3 reviews)

Fundamental Rating

CSII gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. While CSII seems to be doing ok healthwise, there are quite some concerns on its profitability. CSII is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

CSII had negative earnings in the past year.

CSII had a negative operating cash flow in the past year.

In the past 5 years CSII reported 4 times negative net income.

In multiple years CSII reported negative operating cash flow during the last 5 years.

1.2 Ratios

CSII has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CSII has a Gross Margin of 72.39%. This is amongst the best in the industry. CSII outperforms 82.46% of its industry peers.

In the last couple of years the Gross Margin of CSII has declined.

CSII does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	72.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.25%

GM growth 5Y-1.96%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CSII does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CSII has more shares outstanding

The debt/assets ratio for CSII is higher compared to a year ago.

2.2 Solvency

CSII has an Altman-Z score of 6.06. This indicates that CSII is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 6.06, CSII belongs to the top of the industry, outperforming 80.57% of the companies in the same industry.

CSII has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.08, CSII perfoms like the industry average, outperforming 58.29% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Altman-Z	6.06

ROIC/WACCN/A

WACC9.65%

2.3 Liquidity

A Current Ratio of 6.04 indicates that CSII has no problem at all paying its short term obligations.

CSII has a better Current ratio (6.04) than 72.99% of its industry peers.

A Quick Ratio of 4.92 indicates that CSII has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 4.92, CSII is in the better half of the industry, outperforming 72.04% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.04
Quick Ratio	4.92

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CSII shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.97%.

CSII shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.

Measured over the past years, CSII shows a small growth in Revenue. The Revenue has been growing by 2.89% on average per year.

EPS 1Y (TTM)-46.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%13.04%

Revenue 1Y (TTM)-4.73%

Revenue growth 3Y-1.61%

Revenue growth 5Y2.89%

Sales Q2Q%3.92%

3.2 Future

Based on estimates for the next years, CSII will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.08% on average per year.

Based on estimates for the next years, CSII will show a quite strong growth in Revenue. The Revenue will grow by 10.69% on average per year.

EPS Next Y28.21%

EPS Next 2Y21.47%

EPS Next 3Y19.08%

EPS Next 5YN/A

Revenue Next Year8.64%

Revenue Next 2Y9.57%

Revenue Next 3Y10.69%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSII. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSII. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CSII's earnings are expected to grow with 19.08% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y21.47%

EPS Next 3Y19.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CSII!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CARDIOVASCULAR SYSTEMS INC

NASDAQ:CSII (4/27/2023, 8:22:19 PM)

After market: 20 0 (0%)

+0.03 (+0.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-03 2023-05-03/amc

Earnings (Next)07-31 2023-07-31/amc

Inst Owners0%

Inst Owner Change0%

Ins Owners5.24%

Ins Owner Change0%

Market Cap839.18M

Revenue(TTM)239.84M

Net Income(TTM)-37.87M

Analysts48.33

Price Target17.75 (-11.25%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-21.68%

Min EPS beat(2)-28.27%

Max EPS beat(2)-15.09%

EPS beat(4)1

Avg EPS beat(4)-10.65%

Min EPS beat(4)-28.27%

Max EPS beat(4)13.04%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-2.79%

Min Revenue beat(2)-4.49%

Max Revenue beat(2)-1.09%

Revenue beat(4)0

Avg Revenue beat(4)-3.05%

Min Revenue beat(4)-4.49%

Max Revenue beat(4)-1.09%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-13%

EPS NQ rev (1m)0%

EPS NQ rev (3m)7.9%

EPS NY rev (1m)0%

EPS NY rev (3m)1.53%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0.19%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.56%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.5
P/FCF	N/A
P/OCF	N/A
P/B	3.51
P/tB	3.74
EV/EBITDA	N/A

EPS(TTM)-0.97

EYN/A

EPS(NY)-0.5

Fwd EYN/A

FCF(TTM)-0.8

FCFYN/A

OCF(TTM)-0.69

OCFYN/A

SpS5.72

BVpS5.71

TBVpS5.35

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	72.39%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.25%

GM growth 5Y-1.96%

F-Score2

Asset Turnover0.77

Health

		Industry Rank	Sector Rank
Debt/Equity	0.08
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	90.93%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	6.04
Quick Ratio	4.92
Altman-Z	6.06

F-Score2

WACC9.65%

ROIC/WACCN/A

Cap/Depr(3y)91.15%

Cap/Depr(5y)90.95%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-46.97%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%13.04%

EPS Next Y28.21%

EPS Next 2Y21.47%

EPS Next 3Y19.08%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.73%

Revenue growth 3Y-1.61%

Revenue growth 5Y2.89%

Sales Q2Q%3.92%

Revenue Next Year8.64%

Revenue Next 2Y9.57%

Revenue Next 3Y10.69%

Revenue Next 5YN/A

EBIT growth 1Y-41.6%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.76%

EBIT Next 3Y32.49%

EBIT Next 5YN/A

FCF growth 1Y-111.94%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-154.42%

OCF growth 3YN/A

OCF growth 5YN/A

CARDIOVASCULAR SYSTEMS INC / CSII FAQ

What is the fundamental rating for CSII stock?

ChartMill assigns a fundamental rating of 3 / 10 to CSII.

What is the valuation status of CARDIOVASCULAR SYSTEMS INC (CSII) stock?

ChartMill assigns a valuation rating of 1 / 10 to CARDIOVASCULAR SYSTEMS INC (CSII). This can be considered as Overvalued.

What is the profitability of CSII stock?

CARDIOVASCULAR SYSTEMS INC (CSII) has a profitability rating of 0 / 10.

CARDIOVASCULAR SYSTEMS INC (CSII) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CARDIOVASCULAR SYSTEMS INC / CSII FAQ

What is the fundamental rating for CSII stock?

What is the valuation status of CARDIOVASCULAR SYSTEMS INC (CSII) stock?

What is the profitability of CSII stock?